Liver Disease Treatments: The Global Market

Report Code: PHM057D

Publish Date: Apr 2025

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

Limited Period Offer

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.

Report Includes

  • 52 data tables and 63 additional tables
  • Analyses of the trends in the global markets for liver disease treatments, with revenue data from 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
  • Estimates of the size and revenue prospects for the global market, along with a market share analysis by product (drug) type, disease type, route of administration, end user, and region
  • Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations, and the impacts of macroeconomic variables
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • An assessment of the major drugs that can cause liver disease, the market’s current situation and future prospects, clinical trials, new developments, and pipeline products
  • An analysis of the key patent grants and recently published patents
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
  • Analysis of the industry structure, including companies’ product offerings, strategic alliances, M&A activity, venture fundings and investment outlook
  • Company profiles of major players within the industry, including Gilead Sciences Inc., Bristol Myers Squibb Co., AbbVie Inc., and Merck & Co. Inc.

Report Scope

This report on the global market for liver disease treatments provides qualitative and quantitative data on the current market dynamics. It discusses different liver diseases and their treatment modalities.

Analyses of the most frequently used products, clinical trials, new product approvals, and emerging technologies are also included. The demographics of the major regions—North America, Europe, Asia-Pacific, South America, and the Middle East and Africa—as well as their prospects for growth are summarized. The profiles of leading companies in the market and their strategies are also discussed.

The market for liver disease treatments is broken into hepatitis, non-alcoholic fatty liver disease (NAFLD), hepatocellular carcinoma, autoimmune liver diseases, alcohol-induced liver disease (ALD), chronic liver disease, and others. The growth potential and forecast data are discussed for each disease for the aforementioned regions and many countries.

The report includes global revenue in $ millions for the base year of 2024, estimates for 2025, and data for the forecast period of 2026 through 2030.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $46.0 billion
Market size forecast $69.1 billion
Growth rate CAGR of 7.1% for the forecast period of 2025-2030
Units considered $ Millions
Segments covered Disease Type, Region
Regions covered North America, Europe, Asia-Pacific, South America, Rest of the World
Countries covered U.S., Canada, Mexico, U.K., Germany, Spain, Italy, Switzerland, Denmark, Belgium, the Netherlands, Sweden, Russia, China, India, Japan, Australia, South Korea, New Zealand, Singapore, Malaysia, Thailand, Indonesia, Brazil, Argentina, Colombia, Paraguay, Peru, Middle East, Africa
Key Market Drivers
  • Increasing Incidence of Liver Diseases
  • Consumption of Alcohol and Improper Diet
  • Government Initiatives to Provide Vaccines and Grow Awareness
Companies studied
ABBVIE INC.ASTRAZENECA
BAYER AGBIOTEST AG
BRISTOL-MYERS SQUIBB CO.F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.GSK PLC.
MERCK & CO. INC.INTERCEPT PHARMACEUTICALS INC.
MADRIGAL PHARMACEUTICALSNOVARTIS AG
SALIX PHARMACEUTICALSSANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global liver disease treatment market was valued at $46.0 billion in 2024 and is expected to reach $69.1 billion by the end of 2030. The market is expected to grow at a CAGR of 7.1% from 2025 to 2030.
Key factors that are driving the growth are rise in the incidence of liver diseases, increase in the consumption of alcohol and improper diet, and rising government initiatives to provide vaccines and growing awareness.
The market size for liver disease treatment is categorized into seven disease types: hepatitis, non-alcoholic fatty liver disease (NAFLD), hepatocellular carcinoma, autoimmune liver diseases, alcohol-induced liver disease (ALD), chronic liver disease, and others.
Hepatitis will dominate the liver disease treatment market by the end of 2030.
The North American market for liver disease treatment was valued at $20.8 billion in 2024 and is estimated to reach $31.6 billion in 2030, at a CAGR of 7.3% during the forecast period.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Liver Disease Treatments: The Global Market164Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview12Free
Chapter- 3: Market Dynamics9Free
Chapter- 4: Regulatory Landscape4Free
Chapter- 5: Emerging Trends and Pipeline Analysis11Free
Chapter- 6: Market Segmentation Analysis61Free
Chapter- 7: Competitive Intelligence3Free
Chapter- 8: Sustainability in the Liver Disease Treatment Industry: ESG Perspective4Free
Chapter- 9: Appendix 55Free
Published - Jun-2015| Analyst - Yogita Zutshi| Code - PHM057C

Report Highlights

The global liver diseases therapeutics market totaled nearly $24.5 billion in 2014 and is projected to approach $33.8 billion by 2019, registering a compound annual growth rate (CAGR) of 6.7% through 2019.

Report Includes

  • An overview of the global market for liver disease treatment and related technologies.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information regarding market sizes, market leaders, market dynamics, and various other market factors, as well as the liver disease treatment market for end users.
  • Analysis of different liver disease drugs in response to an increasing need for new and innovative drug treatments.
  • Comprehensive profiles of major players as well as the acquisitions, mergers, and alliances by these companies and global organizations.
Published - Jan-2012| Analyst - Shalini Shahani Dewan| Code - PHM057B

Report Highlights

In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did not see much progress, causing overall global sales to remain stagnant at $12.4 billion. Estimated sales in 2011 a projected $12 billion (excluding protease inhibitors).  The market is expected to rise at a CAGR of 3.3% and reach nearly $14.2 billion by 2016.

Published - Jun-2009| Analyst - Shalini Shahani Dewan| Code - PHM057A

Report Highlights

  • The global market for liver disease treatments amounted to nearly $8.4 billion in 2007 and is expected to increase to $9.8 billion in 2014, for a compound annual growth rate (CAGR) of 3.0%
  • The treatment for hepatitis is the largest segment of the market, amounting to about $4.6 billion in the last three years, and is expected to reach $4.8 billion in 2014.
  • Sales of targeted therapies were comparatively less in 2008, but this market has the potential to grow faster mainly because of the increased incidence of hepatitis C in developing countries.

Related Reports

Organ-on-a-Chip: Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO188C

The global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

Published - Mar 2025 | Publisher - BCC Publishing | Code - PHM177C

The global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Recent Reports

Liver Disease Treatments: The Global Market

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM057D

The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.

Cancer Immunotherapy: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM129C

The global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.

Nanotechnology in Cancer Treatment: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM222B

The report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region. The report concludes with profiles of the major players in the market.

Radiopharmaceuticals: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM171C

The global radiopharmaceuticals market is expected to grow from $10.3 billion in 2024 and is projected to reach $21.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 16.4% during the forecast period of 2024 to 2029.

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

Published - Mar 2025 | Publisher - BCC Publishing | Code - PHM177C

The global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.

Top Trending Reports

Carbon Capture, Utilization & Storage Technologies

Published - Feb 2025 | Publisher - BCC Publishing | Code - EGY037G

The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.

Global Diabetic Care Devices Market

Published - Feb 2025 | Publisher - BCC Publishing | Code - MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

2024 Semiconductor Manufacturing Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - SMC086G

This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.

Generative AI: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - IFT308A

The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Liver Disease Treatments: The Global Market
Sample Report